Fetuin A/Nutritional Status Predicts Cardiovascular Outcomes and Survival in Hemodialysis Patients

Background: Fetuin A - a predictor of cardiovascular (CV) outcomes in dialysis patients - is correlated with over-nutrition in the general population. Whether fetuin A and nutritional status interact with each other to alter CV outcomes and survival in hemodialysis (HD) patients remains unknown. Met...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of nephrology Vol. 40; no. 3; pp. 233 - 241
Main Authors Chen, Hung-Yuan, Chiu, Yen-Ling, Hsu, Shih-Ping, Pai, Mei-Fen, Yang, Ju-Yeh, Peng, Yu-Sen
Format Journal Article
LanguageEnglish
Published Basel, Switzerland S. Karger AG 01.01.2014
Subjects
Online AccessGet full text
ISSN0250-8095
1421-9670
1421-9670
DOI10.1159/000366523

Cover

Abstract Background: Fetuin A - a predictor of cardiovascular (CV) outcomes in dialysis patients - is correlated with over-nutrition in the general population. Whether fetuin A and nutritional status interact with each other to alter CV outcomes and survival in hemodialysis (HD) patients remains unknown. Methods: We performed a prospective study on 388 prevalent HD patients. We used the geriatric nutritional risk index (GNRI) for the evaluation of nutritional status. Study outcomes included the occurrence of CV event, CV death, and all-cause mortality during follow-up; interactions between parameters for predicting outcomes were assessed by the interaction terms in a Cox regression model. Results: Overall, 131 patients experienced CV events and 92 patients died, with 51 CV deaths. HD patients with higher fetuin A levels had lower numbers of CV events (adjusted hazard ratio [HR], 0.9; 0.81-0.99) and all-cause mortality (adjusted HR, 0.97; 0.91-0.99). However, patients with higher GNRI had lower all-cause mortality (adjusted HR, 0.79; 0.51-0.98, for every 10-unit increase). Fetuin A levels and GNRI showed a significant interaction in the prediction of CV events (adjusted HR, 1.01; 1.008-1.02) but not for all-cause or CV mortality. In patients with poor nutritional status, higher fetuin A levels were associated with fewer CV events; however, in contrast, in subjects with better nutritional status, higher fetuin A levels appeared to lead to a higher number of CV events. Conclusions: Fetuin A showed a remarkable interaction with nutritional status in evaluating the risks of CV morbidities in prevalent HD patients.
AbstractList Background: Fetuin A - a predictor of cardiovascular (CV) outcomes in dialysis patients - is correlated with over-nutrition in the general population. Whether fetuin A and nutritional status interact with each other to alter CV outcomes and survival in hemodialysis (HD) patients remains unknown. Methods: We performed a prospective study on 388 prevalent HD patients. We used the geriatric nutritional risk index (GNRI) for the evaluation of nutritional status. Study outcomes included the occurrence of CV event, CV death, and all-cause mortality during follow-up; interactions between parameters for predicting outcomes were assessed by the interaction terms in a Cox regression model. Results: Overall, 131 patients experienced CV events and 92 patients died, with 51 CV deaths. HD patients with higher fetuin A levels had lower numbers of CV events (adjusted hazard ratio [HR], 0.9; 0.81-0.99) and all-cause mortality (adjusted HR, 0.97; 0.91-0.99). However, patients with higher GNRI had lower all-cause mortality (adjusted HR, 0.79; 0.51-0.98, for every 10-unit increase). Fetuin A levels and GNRI showed a significant interaction in the prediction of CV events (adjusted HR, 1.01; 1.008-1.02) but not for all-cause or CV mortality. In patients with poor nutritional status, higher fetuin A levels were associated with fewer CV events; however, in contrast, in subjects with better nutritional status, higher fetuin A levels appeared to lead to a higher number of CV events. Conclusions: Fetuin A showed a remarkable interaction with nutritional status in evaluating the risks of CV morbidities in prevalent HD patients.
Fetuin A - a predictor of cardiovascular (CV) outcomes in dialysis patients - is correlated with over-nutrition in the general population. Whether fetuin A and nutritional status interact with each other to alter CV outcomes and survival in hemodialysis (HD) patients remains unknown. We performed a prospective study on 388 prevalent HD patients. We used the geriatric nutritional risk index (GNRI) for the evaluation of nutritional status. Study outcomes included the occurrence of CV event, CV death, and all-cause mortality during follow-up; interactions between parameters for predicting outcomes were assessed by the interaction terms in a Cox regression model. Overall, 131 patients experienced CV events and 92 patients died, with 51 CV deaths. HD patients with higher fetuin A levels had lower numbers of CV events (adjusted hazard ratio [HR], 0.9; 0.81-0.99) and all-cause mortality (adjusted HR, 0.97; 0.91-0.99). However, patients with higher GNRI had lower all-cause mortality (adjusted HR, 0.79; 0.51-0.98, for every 10-unit increase). Fetuin A levels and GNRI showed a significant interaction in the prediction of CV events (adjusted HR, 1.01; 1.008-1.02) but not for all-cause or CV mortality. In patients with poor nutritional status, higher fetuin A levels were associated with fewer CV events; however, in contrast, in subjects with better nutritional status, higher fetuin A levels appeared to lead to a higher number of CV events. Fetuin A showed a remarkable interaction with nutritional status in evaluating the risks of CV morbidities in prevalent HD patients.
Background: Fetuin A - a predictor of cardiovascular (CV) outcomes in dialysis patients - is correlated with over-nutrition in the general population. Whether fetuin A and nutritional status interact with each other to alter CV outcomes and survival in hemodialysis (HD) patients remains unknown. Methods: We performed a prospective study on 388 prevalent HD patients. We used the geriatric nutritional risk index (GNRI) for the evaluation of nutritional status. Study outcomes included the occurrence of CV event, CV death, and all-cause mortality during follow-up; interactions between parameters for predicting outcomes were assessed by the interaction terms in a Cox regression model. Results: Overall, 131 patients experienced CV events and 92 patients died, with 51 CV deaths. HD patients with higher fetuin A levels had lower numbers of CV events (adjusted hazard ratio [HR], 0.9; 0.81-0.99) and all-cause mortality (adjusted HR, 0.97; 0.91-0.99). However, patients with higher GNRI had lower all-cause mortality (adjusted HR, 0.79; 0.51-0.98, for every 10-unit increase). Fetuin A levels and GNRI showed a significant interaction in the prediction of CV events (adjusted HR, 1.01; 1.008-1.02) but not for all-cause or CV mortality. In patients with poor nutritional status, higher fetuin A levels were associated with fewer CV events; however, in contrast, in subjects with better nutritional status, higher fetuin A levels appeared to lead to a higher number of CV events. Conclusions: Fetuin A showed a remarkable interaction with nutritional status in evaluating the risks of CV morbidities in prevalent HD patients. © 2014 S. Karger AG, Basel
Fetuin A - a predictor of cardiovascular (CV) outcomes in dialysis patients - is correlated with over-nutrition in the general population. Whether fetuin A and nutritional status interact with each other to alter CV outcomes and survival in hemodialysis (HD) patients remains unknown.BACKGROUNDFetuin A - a predictor of cardiovascular (CV) outcomes in dialysis patients - is correlated with over-nutrition in the general population. Whether fetuin A and nutritional status interact with each other to alter CV outcomes and survival in hemodialysis (HD) patients remains unknown.We performed a prospective study on 388 prevalent HD patients. We used the geriatric nutritional risk index (GNRI) for the evaluation of nutritional status. Study outcomes included the occurrence of CV event, CV death, and all-cause mortality during follow-up; interactions between parameters for predicting outcomes were assessed by the interaction terms in a Cox regression model.METHODSWe performed a prospective study on 388 prevalent HD patients. We used the geriatric nutritional risk index (GNRI) for the evaluation of nutritional status. Study outcomes included the occurrence of CV event, CV death, and all-cause mortality during follow-up; interactions between parameters for predicting outcomes were assessed by the interaction terms in a Cox regression model.Overall, 131 patients experienced CV events and 92 patients died, with 51 CV deaths. HD patients with higher fetuin A levels had lower numbers of CV events (adjusted hazard ratio [HR], 0.9; 0.81-0.99) and all-cause mortality (adjusted HR, 0.97; 0.91-0.99). However, patients with higher GNRI had lower all-cause mortality (adjusted HR, 0.79; 0.51-0.98, for every 10-unit increase). Fetuin A levels and GNRI showed a significant interaction in the prediction of CV events (adjusted HR, 1.01; 1.008-1.02) but not for all-cause or CV mortality. In patients with poor nutritional status, higher fetuin A levels were associated with fewer CV events; however, in contrast, in subjects with better nutritional status, higher fetuin A levels appeared to lead to a higher number of CV events.RESULTSOverall, 131 patients experienced CV events and 92 patients died, with 51 CV deaths. HD patients with higher fetuin A levels had lower numbers of CV events (adjusted hazard ratio [HR], 0.9; 0.81-0.99) and all-cause mortality (adjusted HR, 0.97; 0.91-0.99). However, patients with higher GNRI had lower all-cause mortality (adjusted HR, 0.79; 0.51-0.98, for every 10-unit increase). Fetuin A levels and GNRI showed a significant interaction in the prediction of CV events (adjusted HR, 1.01; 1.008-1.02) but not for all-cause or CV mortality. In patients with poor nutritional status, higher fetuin A levels were associated with fewer CV events; however, in contrast, in subjects with better nutritional status, higher fetuin A levels appeared to lead to a higher number of CV events.Fetuin A showed a remarkable interaction with nutritional status in evaluating the risks of CV morbidities in prevalent HD patients.CONCLUSIONSFetuin A showed a remarkable interaction with nutritional status in evaluating the risks of CV morbidities in prevalent HD patients.
Author Chiu, Yen-Ling
Chen, Hung-Yuan
Peng, Yu-Sen
Yang, Ju-Yeh
Pai, Mei-Fen
Hsu, Shih-Ping
Author_xml – sequence: 1
  givenname: Hung-Yuan
  surname: Chen
  fullname: Chen, Hung-Yuan
– sequence: 2
  givenname: Yen-Ling
  surname: Chiu
  fullname: Chiu, Yen-Ling
– sequence: 3
  givenname: Shih-Ping
  surname: Hsu
  fullname: Hsu, Shih-Ping
– sequence: 4
  givenname: Mei-Fen
  surname: Pai
  fullname: Pai, Mei-Fen
– sequence: 5
  givenname: Ju-Yeh
  surname: Yang
  fullname: Yang, Ju-Yeh
– sequence: 6
  givenname: Yu-Sen
  surname: Peng
  fullname: Peng, Yu-Sen
  email: taan70@yahoo.com.tw, ClinicalTrials.gov NCT01457625
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25322785$$D View this record in MEDLINE/PubMed
BookMark eNptkUtLAzEURoMo9qEL9yIDbnQx9iaZzGNZilVBVFDXQzpJJDoz0TwK_femtHZRXIS7yDkf3O-O0GFveonQGYYbjFk1AQCa54zQAzTEGcFplRdwiIZAGKQlVGyARs59AmBSQnGMBoRRQoqSDdFiLn3QfTKdPAVvtdem523y6rkPLnmxUujGu2TGrdBmyV0TWm6T5-Ab00mX8F4kr8Eu9TJKMeVedkZo3q6cjjb3WvbenaAjxVsnT7dzjN7nt2-z-_Tx-e5hNn1MG0oznyqF6WKBAbhUhClRZkB5lmcMVwyYJEIwzFQVnyJUCVLmVcYL0hC5NlVFx-hqk_ttzU-Qzteddo1sW95LE1yNc1xRApTQiF7uoZ8m2Lj5miIFxpThIlIXWyosOinqb6s7blf1X3sRuN4AjTXOWal2CIZ6fZl6d5nITvbYRseWY9_ect3-a5xvjC9uP6TdZW-_fwFr9Jc9
CODEN AJNED9
CitedBy_id crossref_primary_10_3389_fphys_2019_00966
crossref_primary_10_1007_s40620_019_00676_1
crossref_primary_10_3390_nu15245036
crossref_primary_10_1016_j_clnu_2016_04_010
crossref_primary_10_1177_2040622320949060
Cites_doi 10.1016/S0140-6736(03)12710-9
10.1016/j.jacc.2011.08.035
10.1002/dmrr.967
10.1038/sj.ki.5002178
10.1093/ndt/gft032
10.1053/j.ajkd.2008.10.046
10.1371/journal.pone.0038415
10.1073/pnas.97.26.14478
10.2337/diacare.29.04.06.dc05-1938
10.1001/2012.jama.11132
10.1016/j.cytogfr.2006.09.002
10.1016/j.jjcc.2013.10.018
10.1016/j.jacc.2008.12.040
10.1093/ndt/gfn303
10.1111/eci.12057
10.1172/JCI17202
10.1161/CIRCULATIONAHA.105.588723
10.1111/j.1523-1755.2005.00345.x
10.1111/j.1365-2362.2008.02032.x
10.1074/jbc.M112234200
10.1159/000117817
10.1093/ndt/gfh891
10.1053/j.ajkd.2010.06.015
10.1053/j.ajkd.2005.09.014
10.1210/jc.2008-1505
10.1530/EJE-08-0813
10.4065/mcp.2010.0336
ContentType Journal Article
Copyright 2014 S. Karger AG, Basel
2014 S. Karger AG, Basel.
Copyright (c) 2014 S. Karger AG, Basel
Copyright_xml – notice: 2014 S. Karger AG, Basel
– notice: 2014 S. Karger AG, Basel.
– notice: Copyright (c) 2014 S. Karger AG, Basel
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QL
7QP
7RV
7T7
7U9
7X7
7XB
88E
88I
8AF
8AO
8FD
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
C1K
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
KB0
M0S
M1P
M2P
M7N
NAPCQ
P64
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
Q9U
S0X
7X8
DOI 10.1159/000366523
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Calcium & Calcified Tissue Abstracts
Nursing & Allied Health Database
Industrial and Applied Microbiology Abstracts (Microbiology A)
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
STEM Database
ProQuest Pharma Collection
Technology Research Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials Local Electronic Collection Information
ProQuest Central
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Health & Medical Collection (Alumni Edition)
Medical Database
Science Database (ProQuest)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Nursing & Allied Health Premium
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central Basic
SIRS Editorial
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Central Student
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
SIRS Editorial
ProQuest Health & Medical Complete (Alumni)
ProQuest AP Science
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Pharma Collection
Environmental Sciences and Pollution Management
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
ProQuest Science Journals (Alumni Edition)
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE
ProQuest Central Student
CrossRef
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1421-9670
EndPage 241
ExternalDocumentID 3505605961
25322785
10_1159_000366523
366523
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.55
.GJ
0R~
0~5
0~B
23M
30W
327
34G
36B
39C
3O-
3O.
3V.
4.4
53G
5GY
5RE
6J9
7RV
7X7
88E
88I
8AF
8AO
8FI
8FJ
8UI
AAWTL
AAYIC
ABJNI
ABPAZ
ABUWG
ACGFO
ACGFS
ACGOD
ACPRK
ACPSR
ADAGL
ADBBV
ADFRT
AENEX
AEYAO
AFFNX
AFJJK
AFKRA
AFRAH
AHMBA
ALDHI
ALIPV
ALMA_UNASSIGNED_HOLDINGS
APPQY
AZPMC
AZQEC
BENPR
BKEYQ
BPHCQ
BVXVI
CAG
CCPQU
COF
CS3
CYUIP
DWQXO
E0A
EBS
EJD
EMB
EMOBN
EX3
F5P
FB.
FYUFA
GNUQQ
HCIFZ
HMCUK
HZ~
IAO
IHR
IHW
IY7
KUZGX
M1P
M2P
N9A
NAPCQ
O1H
O9-
OVD
P2P
PQQKQ
PROAC
PSQYO
RIG
RKO
RXVBD
S0X
SV3
TEORI
UJ6
UKHRP
WOW
X7M
ZGI
ZXP
AAYXX
ABBTS
ABWCG
ACQXL
AFSIO
AHFRZ
CITATION
ITC
PHGZM
PHGZT
PJZUB
PPXIY
PUEGO
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7QP
7T7
7U9
7XB
8FD
8FK
C1K
FR3
H94
K9.
M7N
P64
PKEHL
PQEST
PQUKI
Q9U
7X8
ID FETCH-LOGICAL-c334t-ff13bb100aef25fd8403a464519505e2dd515f915ff23fd28694a72c2eff13f93
IEDL.DBID BENPR
ISSN 0250-8095
1421-9670
IngestDate Wed Oct 01 13:51:17 EDT 2025
Mon Oct 06 16:51:03 EDT 2025
Mon Jul 21 06:06:51 EDT 2025
Thu Apr 24 23:03:33 EDT 2025
Wed Oct 01 06:31:10 EDT 2025
Thu Aug 29 12:04:49 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Cardiovascular outcome
Nutrition
Fetuin A
Survival
Interaction
Language English
License Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
https://www.karger.com/Services/SiteLicenses
2014 S. Karger AG, Basel.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c334t-ff13bb100aef25fd8403a464519505e2dd515f915ff23fd28694a72c2eff13f93
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 25322785
PQID 1627113517
PQPubID 10951
PageCount 9
ParticipantIDs proquest_miscellaneous_1619320323
crossref_primary_10_1159_000366523
pubmed_primary_25322785
crossref_citationtrail_10_1159_000366523
proquest_journals_1627113517
karger_primary_366523
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-01-01
PublicationDateYYYYMMDD 2014-01-01
PublicationDate_xml – month: 01
  year: 2014
  text: 2014-01-01
  day: 01
PublicationDecade 2010
PublicationPlace Basel, Switzerland
PublicationPlace_xml – name: Basel, Switzerland
– name: Switzerland
– name: Basel
PublicationTitle American journal of nephrology
PublicationTitleAlternate Am J Nephrol
PublicationYear 2014
Publisher S. Karger AG
Publisher_xml – name: S. Karger AG
References Ketteler M, Bongartz P, Westenfeld R, et al: Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 2003;361:827-833.1264205010.1016/S0140-6736(03)12710-9
Wang AY, Woo J, Lam CW, et al: Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients. Nephrol Dial Transplant 2005;20:1676-1685.1589993510.1093/ndt/gfh891
Takahashi H, Ito Y, Ishii H, et al: Geriatric nutritional risk index accurately predicts cardiovascular mortality in incident hemodialysis patients. J Cardiol 2014;64:32-36.2436538510.1016/j.jjcc.2013.10.018
Kalantar-Zadeh K, Abbott KC, Salahudeen AK, Kilpatrick RD, Horwich TB: Survival advantages of obesity in dialysis patients. Am J Clin Nutr 2005;81:543-554.15755821
Schafer C, Heiss A, Schwarz A, et al: The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 2003;112:357-366.1289720310.1172/JCI17202
Wang AY, Lam CW, Wang M, et al: Increased circulating inflammatory proteins predict a worse prognosis with valvular calcification in end-stage renal disease: a prospective cohort study. Am J Nephrol 2008;28:647-653.1829265210.1159/000117817
Ix JH, Barrett-Connor E, Wassel CL, et al: The associations of fetuin-A with subclinical cardiovascular disease in community-dwelling persons: the Rancho Bernardo Study. J Am Coll Cardiol 2011;58:2372-2379.2211564210.1016/j.jacc.2011.08.035
Stenvinkel P, Wang K, Qureshi AR, et al: Low fetuin-A levels are associated with cardiovascular death: impact of variations in the gene encoding fetuin. Kidney Int 2005;67:2383-2392.1588228310.1111/j.1523-1755.2005.00345.x
Yamada K, Furuya R, Takita T, et al: Simplified nutritional screening tools for patients on maintenance hemodialysis. Am J Clin Nutr 2008;87:106-113.18175743
Chen HY, Chiu YL, Hsu SP, Pai MF, Yang JY, Peng YS: Low serum fetuin A levels and incident stroke in patients with maintenance haemodialysis. Eur J Clin Invest 2013;43:387-396.2341913310.1111/eci.12057
Honda H, Qureshi AR, Heimburger O, et al: Serum albumin, c-reactive protein, interleukin 6, and fetuin A as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis 2006;47:139-148.1637739510.1053/j.ajkd.2005.09.014
Metry G, Stenvinkel P, Qureshi AR, et al: Low serum fetuin-A concentration predicts poor outcome only in the presence of inflammation in prevalent haemodialysis patients. Eur J Clin Invest 2008;38:804-811.1902169710.1111/j.1365-2362.2008.02032.x
Neeland IJ, Turer AT, Ayers CR, et al: Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. JAMA 2012;308:1150-1159.2299027410.1001/2012.jama.11132
Reinehr T, Roth CL: Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss. J Clin Endocrinol Metab 2008;93:4479-4485.1872815910.1210/jc.2008-1505
Kaushik SV, Plaisance EP, Kim T, et al: Extended-release niacin decreases serum fetuin-A concentrations in individuals with metabolic syndrome. Diabetes Metab Res Rev 2009;25:427-434.1940504410.1002/dmrr.967
Postorino M, Marino C, Tripepi G, Zoccali C, Group CW: Abdominal obesity and all-cause and cardiovascular mortality in end-stage renal disease. J Am Coll Cardiol 2009;53:1265-1272.1935893910.1016/j.jacc.2008.12.040
Kalantar-Zadeh K, Streja E, Kovesdy CP, et al: The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis. Mayo Clin Proc 2010;85:991-1001.2103704210.4065/mcp.2010.0336
Qureshi AR, Alvestrand A, Divino-Filho JC, et al: Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J Am Soc Nephrol 2002;13(suppl 1):S28-S36.11792759
Chen HY, Chiu YL, Chuang YF, et al: Association of low serum fetuin A levels with poor arteriovenous access patency in patients undergoing maintenance hemodialysis. Am J Kidney Dis 2010;56:720-727.2080156810.1053/j.ajkd.2010.06.015
Kazory A, Klein A, Chalopin JM, Ducloux D, Courivaud C: Obesity and atherosclerotic events in chronic hemodialysis patients: a prospective study. Nephrol Dial Transplant 2013;28(suppl 4):iv188-iv194.2417901210.1093/ndt/gft032
Stefan N, Hennige AM, Staiger H, et al: Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 2006;29:853-857.1656782710.2337/diacare.29.04.06.dc05-1938
Chiu YL, Chen HY, Chuang YF, et al: Association of uraemic pruritus with inflammation and hepatitis infection in haemodialysis patients. Nephrol Dial Transplant 2008;23:3685-3689.1851565410.1093/ndt/gfn303
Chen HY, Lin CC, Chiu YL, et al: Serum fetuin A and chemerin levels correlate with hepatic steatosis and regional adiposity in maintenance hemodialysis patients. PLoS One 2012;7:e38415.2281569110.1371/journal.pone.0038415
Hermans MM, Brandenburg V, Ketteler M, et al: Association of serum fetuin-A levels with mortality in dialysis patients. Kidney Int 2007;72:202-207.1734217810.1038/sj.ki.5002178
Pertosa G, Simone S, Ciccone M, et al: Serum fetuin A in hemodialysis: a link between derangement of calcium-phosphorus homeostasis and progression of atherosclerosis? Am J Kidney Dis 2009;53:467-474.1916779810.1053/j.ajkd.2008.10.046
Honda H, Qureshi AR, Axelsson J, et al: Obese sarcopenia in patients with end-stage renal disease is associated with inflammation and increased mortality. Am J Clin Nutr 2007;86:633-638.17823427
Kissebah AH, Sonnenberg GE, Myklebust J, et al: Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proc Natl Acad Sci U S A 2000;97:14478-14483.1112105010.1073/pnas.97.26.14478
Chen HY, Chiu YL, Hsu SP, et al: Association of serum fetuin A with truncal obesity and dyslipidemia in non-diabetic hemodialysis patients. Eur J Endocrinol 2009;160:777-783.1922882310.1530/EJE-08-0813
Singh NN, Ramji DP: The role of transforming growth factor-beta in atherosclerosis. Cytokine Growth Factor Rev 2006;17:487-499.1705629510.1016/j.cytogfr.2006.09.002
Ix JH, Shlipak MG, Brandenburg VM, Ali S, Ketteler M, Whooley MA: Association between human fetuin-A and the metabolic syndrome: data from the heart and soul study. Circulation 2006;113:1760-1767.1656756810.1161/CIRCULATIONAHA.105.588723
Szweras M, Liu D, Partridge EA, et al: Alpha 2-HS glycoprotein/fetuin, a transforming growth factor-beta/bone morphogenetic protein antagonist, regulates postnatal bone growth and remodeling. J Biol Chem 2002;277:19991-19997.1190115510.1074/jbc.M112234200
ref13
ref12
ref15
ref14
ref11
ref10
ref2
ref1
ref17
ref16
ref19
ref18
ref24
ref23
ref26
ref25
ref20
ref22
ref21
ref27
ref8
ref7
ref9
ref4
ref3
ref6
ref5
References_xml – reference: Yamada K, Furuya R, Takita T, et al: Simplified nutritional screening tools for patients on maintenance hemodialysis. Am J Clin Nutr 2008;87:106-113.18175743
– reference: Neeland IJ, Turer AT, Ayers CR, et al: Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. JAMA 2012;308:1150-1159.2299027410.1001/2012.jama.11132
– reference: Wang AY, Woo J, Lam CW, et al: Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients. Nephrol Dial Transplant 2005;20:1676-1685.1589993510.1093/ndt/gfh891
– reference: Honda H, Qureshi AR, Heimburger O, et al: Serum albumin, c-reactive protein, interleukin 6, and fetuin A as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis 2006;47:139-148.1637739510.1053/j.ajkd.2005.09.014
– reference: Szweras M, Liu D, Partridge EA, et al: Alpha 2-HS glycoprotein/fetuin, a transforming growth factor-beta/bone morphogenetic protein antagonist, regulates postnatal bone growth and remodeling. J Biol Chem 2002;277:19991-19997.1190115510.1074/jbc.M112234200
– reference: Ketteler M, Bongartz P, Westenfeld R, et al: Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 2003;361:827-833.1264205010.1016/S0140-6736(03)12710-9
– reference: Chen HY, Chiu YL, Chuang YF, et al: Association of low serum fetuin A levels with poor arteriovenous access patency in patients undergoing maintenance hemodialysis. Am J Kidney Dis 2010;56:720-727.2080156810.1053/j.ajkd.2010.06.015
– reference: Postorino M, Marino C, Tripepi G, Zoccali C, Group CW: Abdominal obesity and all-cause and cardiovascular mortality in end-stage renal disease. J Am Coll Cardiol 2009;53:1265-1272.1935893910.1016/j.jacc.2008.12.040
– reference: Kaushik SV, Plaisance EP, Kim T, et al: Extended-release niacin decreases serum fetuin-A concentrations in individuals with metabolic syndrome. Diabetes Metab Res Rev 2009;25:427-434.1940504410.1002/dmrr.967
– reference: Chiu YL, Chen HY, Chuang YF, et al: Association of uraemic pruritus with inflammation and hepatitis infection in haemodialysis patients. Nephrol Dial Transplant 2008;23:3685-3689.1851565410.1093/ndt/gfn303
– reference: Chen HY, Lin CC, Chiu YL, et al: Serum fetuin A and chemerin levels correlate with hepatic steatosis and regional adiposity in maintenance hemodialysis patients. PLoS One 2012;7:e38415.2281569110.1371/journal.pone.0038415
– reference: Metry G, Stenvinkel P, Qureshi AR, et al: Low serum fetuin-A concentration predicts poor outcome only in the presence of inflammation in prevalent haemodialysis patients. Eur J Clin Invest 2008;38:804-811.1902169710.1111/j.1365-2362.2008.02032.x
– reference: Chen HY, Chiu YL, Hsu SP, Pai MF, Yang JY, Peng YS: Low serum fetuin A levels and incident stroke in patients with maintenance haemodialysis. Eur J Clin Invest 2013;43:387-396.2341913310.1111/eci.12057
– reference: Hermans MM, Brandenburg V, Ketteler M, et al: Association of serum fetuin-A levels with mortality in dialysis patients. Kidney Int 2007;72:202-207.1734217810.1038/sj.ki.5002178
– reference: Singh NN, Ramji DP: The role of transforming growth factor-beta in atherosclerosis. Cytokine Growth Factor Rev 2006;17:487-499.1705629510.1016/j.cytogfr.2006.09.002
– reference: Kalantar-Zadeh K, Abbott KC, Salahudeen AK, Kilpatrick RD, Horwich TB: Survival advantages of obesity in dialysis patients. Am J Clin Nutr 2005;81:543-554.15755821
– reference: Kazory A, Klein A, Chalopin JM, Ducloux D, Courivaud C: Obesity and atherosclerotic events in chronic hemodialysis patients: a prospective study. Nephrol Dial Transplant 2013;28(suppl 4):iv188-iv194.2417901210.1093/ndt/gft032
– reference: Reinehr T, Roth CL: Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss. J Clin Endocrinol Metab 2008;93:4479-4485.1872815910.1210/jc.2008-1505
– reference: Chen HY, Chiu YL, Hsu SP, et al: Association of serum fetuin A with truncal obesity and dyslipidemia in non-diabetic hemodialysis patients. Eur J Endocrinol 2009;160:777-783.1922882310.1530/EJE-08-0813
– reference: Pertosa G, Simone S, Ciccone M, et al: Serum fetuin A in hemodialysis: a link between derangement of calcium-phosphorus homeostasis and progression of atherosclerosis? Am J Kidney Dis 2009;53:467-474.1916779810.1053/j.ajkd.2008.10.046
– reference: Schafer C, Heiss A, Schwarz A, et al: The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 2003;112:357-366.1289720310.1172/JCI17202
– reference: Ix JH, Shlipak MG, Brandenburg VM, Ali S, Ketteler M, Whooley MA: Association between human fetuin-A and the metabolic syndrome: data from the heart and soul study. Circulation 2006;113:1760-1767.1656756810.1161/CIRCULATIONAHA.105.588723
– reference: Wang AY, Lam CW, Wang M, et al: Increased circulating inflammatory proteins predict a worse prognosis with valvular calcification in end-stage renal disease: a prospective cohort study. Am J Nephrol 2008;28:647-653.1829265210.1159/000117817
– reference: Honda H, Qureshi AR, Axelsson J, et al: Obese sarcopenia in patients with end-stage renal disease is associated with inflammation and increased mortality. Am J Clin Nutr 2007;86:633-638.17823427
– reference: Qureshi AR, Alvestrand A, Divino-Filho JC, et al: Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J Am Soc Nephrol 2002;13(suppl 1):S28-S36.11792759
– reference: Stefan N, Hennige AM, Staiger H, et al: Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 2006;29:853-857.1656782710.2337/diacare.29.04.06.dc05-1938
– reference: Kalantar-Zadeh K, Streja E, Kovesdy CP, et al: The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis. Mayo Clin Proc 2010;85:991-1001.2103704210.4065/mcp.2010.0336
– reference: Kissebah AH, Sonnenberg GE, Myklebust J, et al: Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proc Natl Acad Sci U S A 2000;97:14478-14483.1112105010.1073/pnas.97.26.14478
– reference: Ix JH, Barrett-Connor E, Wassel CL, et al: The associations of fetuin-A with subclinical cardiovascular disease in community-dwelling persons: the Rancho Bernardo Study. J Am Coll Cardiol 2011;58:2372-2379.2211564210.1016/j.jacc.2011.08.035
– reference: Takahashi H, Ito Y, Ishii H, et al: Geriatric nutritional risk index accurately predicts cardiovascular mortality in incident hemodialysis patients. J Cardiol 2014;64:32-36.2436538510.1016/j.jjcc.2013.10.018
– reference: Stenvinkel P, Wang K, Qureshi AR, et al: Low fetuin-A levels are associated with cardiovascular death: impact of variations in the gene encoding fetuin. Kidney Int 2005;67:2383-2392.1588228310.1111/j.1523-1755.2005.00345.x
– ident: ref3
  doi: 10.1016/S0140-6736(03)12710-9
– ident: ref14
  doi: 10.1016/j.jacc.2011.08.035
– ident: ref19
  doi: 10.1002/dmrr.967
– ident: ref2
  doi: 10.1038/sj.ki.5002178
– ident: ref25
  doi: 10.1093/ndt/gft032
– ident: ref15
  doi: 10.1053/j.ajkd.2008.10.046
– ident: ref8
  doi: 10.1371/journal.pone.0038415
– ident: ref22
  doi: 10.1073/pnas.97.26.14478
– ident: ref17
  doi: 10.2337/diacare.29.04.06.dc05-1938
– ident: ref24
  doi: 10.1001/2012.jama.11132
– ident: ref12
  doi: 10.1016/j.cytogfr.2006.09.002
– ident: ref27
  doi: 10.1016/j.jjcc.2013.10.018
– ident: ref26
  doi: 10.1016/j.jacc.2008.12.040
– ident: ref21
  doi: 10.1093/ndt/gfn303
– ident: ref6
  doi: 10.1111/eci.12057
– ident: ref1
  doi: 10.1172/JCI17202
– ident: ref18
  doi: 10.1161/CIRCULATIONAHA.105.588723
– ident: ref4
  doi: 10.1111/j.1523-1755.2005.00345.x
– ident: ref20
  doi: 10.1111/j.1365-2362.2008.02032.x
– ident: ref13
  doi: 10.1074/jbc.M112234200
– ident: ref10
  doi: 10.1159/000117817
– ident: ref11
  doi: 10.1093/ndt/gfh891
– ident: ref5
  doi: 10.1053/j.ajkd.2010.06.015
– ident: ref9
  doi: 10.1053/j.ajkd.2005.09.014
– ident: ref16
  doi: 10.1210/jc.2008-1505
– ident: ref7
  doi: 10.1530/EJE-08-0813
– ident: ref23
  doi: 10.4065/mcp.2010.0336
SSID ssj0012807
Score 2.0686338
Snippet Background: Fetuin A - a predictor of cardiovascular (CV) outcomes in dialysis patients - is correlated with over-nutrition in the general population. Whether...
Fetuin A - a predictor of cardiovascular (CV) outcomes in dialysis patients - is correlated with over-nutrition in the general population. Whether fetuin A and...
SourceID proquest
pubmed
crossref
karger
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 233
SubjectTerms Aged
alpha-2-HS-Glycoprotein - chemistry
Body Weight
Cardiovascular Diseases - mortality
Cardiovascular Diseases - physiopathology
Female
Humans
Kidney Failure, Chronic - complications
Kidney Failure, Chronic - mortality
Kidney Failure, Chronic - therapy
Male
Middle Aged
Nutritional Status
Original Report: Patient-Oriented, Translational Research
Prevalence
Proportional Hazards Models
Prospective Studies
Regression Analysis
Renal Dialysis - mortality
Treatment Outcome
Title Fetuin A/Nutritional Status Predicts Cardiovascular Outcomes and Survival in Hemodialysis Patients
URI https://karger.com/doi/10.1159/000366523
https://www.ncbi.nlm.nih.gov/pubmed/25322785
https://www.proquest.com/docview/1627113517
https://www.proquest.com/docview/1619320323
Volume 40
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1421-9670
  dateEnd: 20151130
  omitProxy: true
  ssIdentifier: ssj0012807
  issn: 0250-8095
  databaseCode: 7X7
  dateStart: 19960101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl: http://www.proquest.com/pqcentral?accountid=15518
  eissn: 1421-9670
  dateEnd: 20151130
  omitProxy: true
  ssIdentifier: ssj0012807
  issn: 0250-8095
  databaseCode: BENPR
  dateStart: 19960101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB61W4S4IB4FFkplEAcu0SZ-xM0BoVJ1tULqsgIq7S2yY1tCQLZskv_PTOIEVQIOySGZzMFjz3zxeL4BeBNSq6wJLhGVNolUWiZFqNIkVFbkRsgqDZTRvVrnq2v5cau2B7Aea2HoWOXoE3tH7XYV7ZEvspzrjNrJ6fc3vxLqGkXZ1bGFhomtFdy7nmLsEI44MWPN4OjD5Xrzecor8FhAjYEffXOhItcQxvRFT82SKy5uRag73-lA9v7f-LOPQ8sHcD8CSHY-WPwhHPj6Edy9iinyx2CXvu2-1ex8sR6J9lGcMGXXsM2e5NqGXdw6hso-dS2Ogm-YqR370qH7wAnIUMvK_9xRaQnxlrDNwMHaHMP18vLrxSqJjRSSSgjZJiFkwtosTY0PXAWHP3XCUEqTesAqz51DVBMKvAIXwfGzvJBG84p7-jIU4gnM6l3tnwFDFTLTZ9JYk0mF0d4hZtB4D9Jn1vk5vB0Hr6wiyzg1u_hR9n8bqiincZ7D60n0ZqDW-JvQ8WCBSWR8fjIapIyrrin_zJE5vJpe43qhJIip_a4jGYKsqSAVTwdDTqq5ElQZrJ7_X_kLuIewSQ4bMScwa_edf4nQpLWncKi3-jTOut9agOII
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3fT9RAEN4QIOqLEUU9RV2IJr401-6Plj4Qg8DlEO68KCS8ld3ubmLAHl7bGP45_jZn2m0NifjGQ_vQTudhdrrz7c7ON4S8d6GWWjkT8DxRgZCJCFKXh4HLNY8VF3noMKM7mcbjU_HlTJ4tkZuuFgaPVXZzYjNRm3mOe-TDKGZJhO3kkk9XvwLsGoXZ1a6FhvKtFcxOQzHmCzuO7PVvWMKVO4f7MN4fGBsdnOyNA99lIMg5F1XgXMS1jsJQWcekM7Di4QrzfdggVVpmDIR8l8LlGHeGbcepUAnLmcUvHZIxQQhYEVyksPhb-XwwnX3r8xjMF2wD0IBYkErPbQQYYthQwcSS8VsRcfUCD4Av7sa7TdwbPSGPPWClu62HrZElWzwlDyY-Jf-M6JGt6h8F3R1OO2J_EEcMW5d0tkC5qqR7t4690q91BVa3JVWFod9rmK7A4SloGdufcyxlQZ4UOms5X8t1cnovJn1Olot5YV8SCipElGwLpVUkJKALAxglgbsTNtLGDsjHznhZ7lnNsbnGZdasbmSa9XYekK1e9Kql8viX0Ho7Ar1I93yjG5DM_-Vl9tcnB2Szfw3_JyZdVGHnNcogRA45qnjRDmSvmkmOlcjy1f-VvyMPxyeT4-z4cHr0mjwCyCbaTaANslwtavsGYFGl33rfo-T8vt39D0wcHeY
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB5VBVVcEI9CFwoYBBKXaBM_4uaAUNWy2lK6rASV9hbs2JYQkC2bRIi_xq9jJi9UCbj1kBySyRzsycw3nhfA8xBbZU1wkSi0iaTSMspCEUehsCI1QhZxoIju2SKdn8u3K7Xagl9DLQylVQ46sVXUbl3QGfk0SblOaJycnoY-LWJ5PHt98T2iCVIUaR3GaXQicup__kD3rXp1cox7_YLz2ZuPR_OonzAQFULIOgohEdYmcWx84Co49HaEoVgfDUdVnjuH5j5keAUuguMHaSaN5gX39GWgRkyo_q9pITJKJ9Sr0dlLeF-qjRADrUCm-q5GiB6mbROYVHFxyRZe_0Kp35t_I93W4s1uwc0eqrLDTrZuw5Yv78DOWR-Mvwt25uvmc8kOp4uhpT-SE3ptKrbcEF1dsaNLCa_sfVPjevuKmdKxDw0qKhR1hlzm_tuailioQwpbdt1eq104v5IFvQfb5br0e8CQhUz0gTTWJFIhrnCITjTeg_SJdX4CL4fFy4u-nzmN1fiat36NyvJxnSfwbCS96Jp4_I1ot9uBkWR4vj9sSN7_31X-Rxon8HR8jX8mhVtM6dcN0RA4jgWxuN9t5MiaK0E1yOrB_5k_gR0U8vzdyeL0IdxArCa705992K43jX-EeKi2j1vBY_DpqiX9N22RG4A
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Fetuin+A%2FNutritional+Status+Predicts+Cardiovascular+Outcomes+and+Survival+in+Hemodialysis+Patients&rft.jtitle=American+journal+of+nephrology&rft.au=Chen%2C+Hung-Yuan&rft.au=Chiu%2C+Yen-Ling&rft.au=Hsu%2C+Shih-Ping&rft.au=Pai%2C+Mei-Fen&rft.date=2014-01-01&rft.issn=0250-8095&rft.eissn=1421-9670&rft.volume=40&rft.issue=3&rft.spage=233&rft.epage=241&rft_id=info:doi/10.1159%2F000366523&rft.externalDBID=n%2Fa&rft.externalDocID=10_1159_000366523
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0250-8095&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0250-8095&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0250-8095&client=summon